Anti-Aggregative Therapy and Laser Iridectomy | NCT00426400

Studies
Anti-Aggregative Therapy and Laser Iridectomy

NCT00426400

Sponsor

Sheba Medical Center

Status

Unknown status

Last Update Posted

Jan 24, 2007Estimated

Enrollment

Not provided

Phase

Phase 4

Conditions

Eyes With Narrow Angle

Interventions

The cessation of anti-aggregative treatment for 10 days

Countries

Israel

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jan 2007

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Mar 2006

Primary Completion Date

Not provided

Completion Date

Not provided

First Submitted Date

Oct 25, 2006

First Submission Date that Met QC Criteria

Jan 23, 2007

First Posted Date

Jan 24, 2007Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jan 23, 2007

Last Update Posted Date

Jan 24, 2007Estimated

Description Module

Brief Summary

Our study investigates the effect of anti-aggregative treatment on success and complications of laser iridectomy. The study includes patients scheduled for laser iridectomy due to narrow angles.Patients will undergo first laser treatment with the anti-aggregative treatment and will scheduled for next lase in the other eye after discontinuing the anti-aggregative treatment. The patients will be followed-up for 3 months.

Detailed Description

Not provided

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Phase 4

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

Not provided

Name	Type	Description	Arm Group Labels	Other Names
The cessation of anti-aggregative treatment for 10 days	Drug

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

patients with narrow angle that need laser iridectomy and take anti- aggregative treatment
over 20 years old
patients who can stop their anti-aggregative treatment for 10 days

Exclusion Criteria:

under coumadin treatment
post ocular surgeries

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

20 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Hani Levkovitch-Verbin, MD	Contact			Hani.Verbin@ sheba.health.gov.il

Overall Officials

Name	Affiliation	Role
Hani Levkovitch-Verbin, MD	Goldscheleger Eye Institute, Sheba Medical Center	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Goldschleger Eye Institute	Recruiting	Tel Litwinsky			Israel